MDT

87.56

+0.44%↑

A

114.42

-2.15%↓

VEEV

160

-7.43%↓

HQY

83.34

+1.87%↑

TLRY

6.65

-1.92%↓

MDT

87.56

+0.44%↑

A

114.42

-2.15%↓

VEEV

160

-7.43%↓

HQY

83.34

+1.87%↑

TLRY

6.65

-1.92%↓

MDT

87.56

+0.44%↑

A

114.42

-2.15%↓

VEEV

160

-7.43%↓

HQY

83.34

+1.87%↑

TLRY

6.65

-1.92%↓

MDT

87.56

+0.44%↑

A

114.42

-2.15%↓

VEEV

160

-7.43%↓

HQY

83.34

+1.87%↑

TLRY

6.65

-1.92%↓

MDT

87.56

+0.44%↑

A

114.42

-2.15%↓

VEEV

160

-7.43%↓

HQY

83.34

+1.87%↑

TLRY

6.65

-1.92%↓

Search

Cytek Biosciences Inc

Deschisă

SectorSănătate

4.6 -2.75

Rezumat

Modificarea prețului

24h

Curent

Minim

4.45

Maxim

4.6899999999999995

Indicatori cheie

By Trading Economics

Venit

-39M

-44M

Vânzări

9.8M

62M

Marjă de profit

-70.929

Angajați

702

EBITDA

4M

-263K

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+35.87% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

20M

581M

Deschiderea anterioară

7.35

Închiderea anterioară

4.6

Sentimentul știrilor

By Acuity

50%

50%

168 / 349 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bullish Evidence

Cytek Biosciences Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 apr. 2026, 20:44 UTC

Câștiguri

Costco Reports 11% Growth in March Sales

8 apr. 2026, 23:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8 apr. 2026, 23:51 UTC

Market Talk

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

8 apr. 2026, 23:36 UTC

Market Talk
Evenimente importante

Gold Edges Lower on Likely Technical Correction -- Market Talk

8 apr. 2026, 22:56 UTC

Market Talk

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

8 apr. 2026, 22:45 UTC

Market Talk

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

8 apr. 2026, 22:17 UTC

Market Talk

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

8 apr. 2026, 21:52 UTC

Evenimente importante

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

8 apr. 2026, 21:24 UTC

Câștiguri

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

8 apr. 2026, 21:01 UTC

Evenimente importante

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

8 apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

8 apr. 2026, 20:43 UTC

Achiziții, Fuziuni, Preluări

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

8 apr. 2026, 20:43 UTC

Achiziții, Fuziuni, Preluări

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

8 apr. 2026, 20:43 UTC

Achiziții, Fuziuni, Preluări

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

8 apr. 2026, 20:42 UTC

Achiziții, Fuziuni, Preluări

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

8 apr. 2026, 20:42 UTC

Achiziții, Fuziuni, Preluări

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

8 apr. 2026, 20:42 UTC

Achiziții, Fuziuni, Preluări

Oracle Responds to TRC Cap Mini-Tender Offer

8 apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 apr. 2026, 20:11 UTC

Achiziții, Fuziuni, Preluări

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

8 apr. 2026, 20:11 UTC

Achiziții, Fuziuni, Preluări

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

8 apr. 2026, 20:11 UTC

Achiziții, Fuziuni, Preluări

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

8 apr. 2026, 19:44 UTC

Câștiguri

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

8 apr. 2026, 19:16 UTC

Market Talk

Hogs Follow Cutout Prices Lower -- Market Talk

8 apr. 2026, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

8 apr. 2026, 19:02 UTC

Market Talk

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

8 apr. 2026, 18:58 UTC

Market Talk

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

8 apr. 2026, 18:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8 apr. 2026, 18:51 UTC

Market Talk

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

8 apr. 2026, 18:14 UTC

Evenimente importante

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

8 apr. 2026, 18:05 UTC

Evenimente importante

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Comparație

Modificare preț

Cytek Biosciences Inc Așteptări

Obiectiv de preț

By TipRanks

35.87% sus

Prognoză pe 12 luni

Medie 6.25 USD  35.87%

Maxim 7.5 USD

Minim 5 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCytek Biosciences Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

1

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

3.7 / 3.8Suport & Rezistență

Termen scurt

Weak Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

168 / 349 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
help-icon Live chat